| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $30.4M | +39.2% |
| Cost of Revenue | $12.6M | -8.7% |
| Gross Profit | $17.8M | +121.0% |
| R&D Expense | $730K | -28.4% |
| SG&A Expense | $8.6M | -10.6% |
| Operating Income | $65K | +101.6% |
| Pre-tax Income | -$5.3M | -6.8% |
| Income Tax | -$137K | -2.4% |
| Net Income | -$1.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.1M | +109.5% |
| Short-term Investments | $4.5M | +599.9% |
| Accounts Receivable | $2.0M | -25.7% |
| Current Assets | $9.4M | +71.4% |
| Total Assets | $14.0M | -28.8% |
| Current Liabilities | $7.4M | +14.0% |
| Long-term Debt | $1.7M | -23.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.8M | -10.2% |
| Capital Expenditures | $7K | -98.6% |
| Investing Cash Flow | $6.3M | +456.5% |
| Financing Cash Flow | -$319K | -334.0% |
| Free Cash Flow | -$4.8M | +1.5% |
| +64.6% |
| EPS (Basic) | -$0.07 | +66.7% |
| EPS (Diluted) | -$0.07 | +66.7% |
| Total Liabilities |
| $10.5M |
| -12.2% |
| Stockholders' Equity | $4.7M | -9.9% |